From January 1, 2023 to March 22, 2023, the company has repurchased 331,100 shares, representing 0.9% for ¥1,122.92 million. With this, the company has completed the repurchase of 1,036,200 shares, representing 2.78% for ¥3,499.72 million under the buyback announced on August 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,995 JPY | -0.33% | -1.96% | -8.41% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.41% | 683M | |
+37.78% | 723B | |
+30.45% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.57% | 244B | |
-4.58% | 208B | |
+10.10% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 1, 2022.